A Council of the Chamber of Commerce for Greater Philadelphia
LinkedInTwitterYouTube

HHS Secretary Becerra Joins U.S. Senator Casey for Visit with Leaders in Greater Philadelphia’s Life Sciences Ecosystem

Greater Philadelphia has the assets and capacity to accelerate science and patient care in the next biotech revolution, and leaders in the region’s life sciences ecosystem had a chance to show that last week when U.S. Senator Bob Casey and the Chamber of Commerce for Greater Philadelphia welcomed the Honorable Xavier Becerra, U.S. Department of Health and Human Services Secretary, for a visit. Among the topics for the October 21, 2022, roundtable discussion were developing breakthrough treatments for genetic and life-threatening diseases and collaborating on innovative solutions to grow the region’s life sciences workforce.

Leaders of Greater […]

October 26th, 2022|Cell and Gene Therapy, Life Sciences, Our News|0 Comments
Read More

“Why Greater Philadelphia Ranks #2 As CGT Hub” Featured in Cell & Gene

The Chamber of Commerce for Greater Philadelphia commissioned a study conducted by Econsult Solutions, Inc., titled The State of Cell and Gene Therapy in the Greater Philadelphia Region: A Comparative Analysis, which measured the impact of our region’s progress in cell and gene therapy through five key lenses: research infrastructure, human capital, innovation output, commercial activity, and value proposition. The study compared Greater Philadelphia to 14 other U.S. metros – Baltimore, Boston, Chicago, Cleveland, Houston, Indianapolis, Los Angeles, New York, Research Triangle, San Diego, San Francisco, Seattle, and Washington D.C. – […]

October 11th, 2022|Awards/Rankings, Cell and Gene Therapy, Life Sciences, Our News, Publications|0 Comments
Read More

Comparative Study Ranks Philadelphia Region #2 Among 14 Cell and Gene Therapy Hubs

Philadelphia Region Now Tops Other Regional Hubs in Five Categories

PHILADELPHIA (September 27, 2022) – In a newly released study comparing 14 U.S. cell and gene therapy hubs in five key categories, the Philadelphia region ranks #2 among U.S. locations. Commissioned by the Chamber of Commerce for Greater Philadelphia and researched by economic consulting firm Econsult Solutions, Inc. (ESI), the study compares cell and gene therapy hubs in research infrastructure, human capital, innovation output, commercial activity, and value proposition. The only region ranked higher overall than Philadelphia was Boston. New York and San Francisco were ranked #3 and […]

September 28th, 2022|Awards/Rankings, Cell and Gene Therapy, Life Sciences, Our News, Press Releases|0 Comments
Read More

Philadelphia Region’s Ever-Expanding Cell and Gene Therapy Family Tree Featured in New Promotional Reel

An initiative launched more than three years ago to boost awareness of the region as a hub for cell and gene therapy is getting ready to unveil its latest effort to promote the fast-growing sector.

Called “Greater Philadelphia: Discovery Starts Here,” the 90-second graphic animation illustrates how more than a dozen companies have spun out of, or are licensing technology from, a handful of local research institutions. It is also available for download here.

Specifically, the video animation features five research institutions (The University of Pennsylvania, Children’s Hospital of Philadelphia, Jefferson Health, Temple University, and The Wistar […]

August 16th, 2022|Cell and Gene Therapy, Life Sciences, Our News, Regional News Roundup|0 Comments
Read More

New Animation Illustrates Greater Philadelphia Region’s Connected Cell and Gene Therapy Startup Ecosystem

PHILADELPHIA (August 16, 2022) – Greater Philadelphia has a new tool to tell the story of collaboration and connectivity in the region’s hub for cell and gene therapy. Titled “Greater Philadelphia: Discovery Starts Here,” the 90-second video animation shares a snapshot of several of the region’s world-class research institutions and a number of the cell and gene therapy companies that have licensed technologies or spun out from them. The video animation was created by the Chamber of Commerce for Greater Philadelphia’s CEO Council for Growth with its partners in the Cell & Gene Therapy Initiative.

“Our region is […]

August 16th, 2022|Cell and Gene Therapy, Life Sciences, Our News, Press Releases|0 Comments
Read More

Greater Philadelphia Region Seeks ARPA-H Home Letter to HHS Secretary Points Out Region’s Significant Assets

PHILADELPHIA (June 29, 2022) – The Chamber of Commerce for Greater Philadelphia today announced the region’s intention to seek to be the new home for a recently announced $1 billion federal agency, the Advanced Research Projects Agency for Health (ARPA-H), which is expected to be located outside of Washington D.C. In a letter sent to the U.S. Health & Human Services Department Secretary Xavier Becerra and signed by business, civic, and elected officials, signers tout the region’s expertise in cell & gene therapy and gene editing, its rank as one of the top eight life sciences […]

June 29th, 2022|Cell and Gene Therapy, Largest Employers, Life Sciences, Media Resources, Our News, Press Releases|0 Comments
Read More

Penn Announces Strategic Partnership with Longfellow Real Estate to Develop State-of-the-Art Life Sciences Facility in Philadelphia

Pennovation Works is a vibrant and growing community in the Greater Philadelphia region with innovative companies doing impactful research and product development.

The Chamber of Commerce for Greater Philadelphia is excited to celebrate with the University of Pennsylvania its announcement of a strategic partnership with Longfellow Real Estate to develop a 455,000-sq.-ft., state-of-the-art life sciences facility inside the Pennovation Works ecosystem.

Read more about this exciting expansion in the press release and full article, which can be found here: https://penntoday.upenn.edu/news/365-million-development-will-expand-life-sciences-hub-pennovation-works.

[…]

June 16th, 2022|Cell and Gene Therapy, Largest Employers, Life Sciences, Our News, Real Estate|0 Comments
Read More

Regional Leaders Praise Greater Philadelphia’s Culture, Cuisine, and Quality of Life

Life sciences companies looking to locate in Greater Philadelphia consider many factors in their decision making, from accessibility and connectivity to opportunities to collaborate and achieve their company’s vision. Another factor is the quality of life available to their employees. The Chamber of Commerce for Greater Philadelphia is developing a series of testimonial videos with Greater Philadelphia’s leaders describing the region’s attributes.

Among the region’s leaders who have already shared their perspectives are Chellie Cameron, CEO, Philadelphia International Airport and Northeast Philadelphia Airport, Chief Aviation Representative, City of Philadelphia – Division of Aviation; Roland Kolbeck, Ph.D., chief scientific officer at Spirovant […]

April 26th, 2022|Cell and Gene Therapy, Life Sciences, Livability|0 Comments
Read More

Medaglio to Direct Chamber’s Businesses Attraction & Expansion Efforts

The Chamber of Commerce for Greater Philadelphia is pleased to announce James Medaglio as Director, Business Attraction & Expansion. In this role, Medaglio will identify, engage, and assist companies looking to locate or expand in the Greater Philadelphia region.

It’s an assignment that Medaglio understands well. He first joined the Chamber in 2018 as a research analyst, providing support to business attraction projects, and more recently, serving as the point of contact for the organization’s Health and Life Sciences Action Team (HLSAT). He is looking forward to drawing on that expertise in his new position.

Among his responsibilities will be hosting visiting […]

February 28th, 2022|Advanced Manufacturing, Cell and Gene Therapy, Financial Services, Life Sciences, Our News, Technology|0 Comments
Read More

Surge in Life Sciences Investment in Region Continues: 2021 Total Exceeded $12 Billion

The life sciences sector in Greater Philadelphia benefited from robust investment in 2021. The 11-county area of Southeastern Pennsylvania, northern Delaware and southern New Jersey combined saw more than $12 billion invested, according to biopharma database company DealForma. The $12 billion tally included more than $3 billion for cell and gene therapy. Investment deals ranged from Series A rounds through IPOs. Among the technologies funded were biologics, cell and gene therapy, small molecules, as well as medical device and digital health, including artificial intelligence.

Reflected in the DealForma data were eight IPOs with a combined value of more than $750 million. […]

January 25th, 2022|Cell and Gene Therapy, Innovation, Investments, Life Sciences, Real Estate, Regional News Roundup|0 Comments
Read More
Go to Top